Fate Therapeutics Inc. Stock
A loss of -2.420% shows a downward development for Fate Therapeutics Inc..
Our community is currently high on Fate Therapeutics Inc. with 4 Buy predictions and 1 Sell predictions.
With a target price of €86.00 there is a positive potential of 30.106% for Fate Therapeutics Inc. compared to the current price of €66.10.
So far the community has only identified positive things for Fate Therapeutics Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Fate Therapeutics Inc. in the next few years
Pros
1
Could be worthwhile Investment >10% per year
1
Future proof or reliable business model
1
Some uniques
Cons
0
-
Performance of Fate Therapeutics Inc. vs. its peers
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Fate Therapeutics Inc. | -2.420% | 3.606% | -5.833% | 135.417% | -10.789% | - | - |
| Sesen Bio Inc | 1.250% | -8.979% | -29.455% | 285.436% | 78.982% | 65.172% | - |
| Lexicon Pharmaceuticals Inc. | -2.580% | -6.389% | -24.643% | 128.479% | 60.091% | -39.017% | -66.240% |
| Aclaris Therapeutics Inc | -1.530% | -8.553% | 6.361% | 1885.714% | 316.168% | - | - |
Comments
Other discussions about Fate Therapeutics Inc. Stock
Trading Fate Therapeutics Inc.
Trading Fate Therapeutics Inc.
